195 related articles for article (PubMed ID: 2853459)
1. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
[TBL] [Abstract][Full Text] [Related]
2. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
[TBL] [Abstract][Full Text] [Related]
3. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
[TBL] [Abstract][Full Text] [Related]
4. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
5. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
[TBL] [Abstract][Full Text] [Related]
6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
7. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin prophylaxis in elective hip surgery.
Turpie AG
Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
[TBL] [Abstract][Full Text] [Related]
11. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Hull RD; Gent M
N Engl J Med; 1986 Oct; 315(15):925-9. PubMed ID: 3531851
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
[TBL] [Abstract][Full Text] [Related]
15. Prevention of deep-vein thrombosis following total hip replacement surgery with enoxaparin versus unfractionated heparin: a pharmacoeconomic evaluation.
Menzin J; Richner R; Huse D; Colditz GA; Oster G
Ann Pharmacother; 1994 Feb; 28(2):271-5. PubMed ID: 8173149
[TBL] [Abstract][Full Text] [Related]
16. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis.
Turpie AG
Am J Surg; 1991 Apr; 161(4):532-6. PubMed ID: 1852136
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
Spiro TE; Johnson GJ; Christie MJ; Lyons RM; MacFarlane DE; Blasier RB; Tremaine MD
Ann Intern Med; 1994 Jul; 121(2):81-9. PubMed ID: 8017740
[TBL] [Abstract][Full Text] [Related]
20. [Double-blind randomized comparative study of enoxaparin and standard heparin in the prevention of thromboembolic disease during insertion of total hip replacement].
Planes A; Vochelle N; Mazas F; Mansat C; Zucman G; Landais A; Weill D; Pascariello JC; Butel J
Rev Med Interne; 1988; 9(3):327-33. PubMed ID: 2841742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
